| Authors: |
Russo M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Valentini E; Department of Biology, University of Rome Tor Vergata, Rome, Italy., Aliperti V; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Copparoni F; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Linkous A; Department of Pharmacology, Vanderbilt University, Nashville, TN, United States., Montaldo C; National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Soddu S; Unit of Cellular Networks and Molecular Therapeutic Targets, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Besson JM; Institut des Biomolécules Max Mousseron (IBMM), CNRS-UM-ENSCM, Montpellier, France., Lopez M; Institut des Biomolécules Max Mousseron (IBMM), CNRS-UM-ENSCM, Montpellier, France., Helmer Citterich M; Department of Biology, University of Rome Tor Vergata, Rome, Italy., Michienzi A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Tripodi M; National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Ciafrè SA; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. Electronic address: ciafre@uniroma2.it., Galardi S; Department of Biology, University of Rome Tor Vergata, Rome, Italy. Electronic address: silvia.galardi@uniroma2.it. |
